Skip to main content

MW 514.63 g/mol, Purity >99%.

Selective AT1 receptor antagonist (Ki = 3.7 nM) . Partial PPAR-γ agonist.

Be the first to review this product! Submit a review

Images

Chemical Structure - Telmisartan, angiotensin II (AT1) antagonist (AB120831), expandable thumbnail
  • Functional Studies - Telmisartan, angiotensin II (AT1) antagonist (AB120831), expandable thumbnail

Publications

Key facts

CAS number
144701-48-4
Purity
> 99%
Form
Solid
Molecular weight
514.63 g/mol
Nature
Synthetic

Recommended products

MW 514.63 g/mol, Purity >99%.

Selective AT1 receptor antagonist (Ki = 3.7 nM) . Partial PPAR-γ agonist.

Key facts

Purity
> 99%
Solubility

Soluble in DMSO to 10 mM.

Biological description

Selective AT1 receptor antagonist (Ki = 3.7 nM) . Partial PPAR-γ agonist.

IUPAC name
4'-[(1,4'-Dimethyl-2'-propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl][1,1'-biphenyl]-2-carboxylic acid

Storage

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
Ambient
Appropriate long-term storage conditions
Ambient
Storage information
The product can be stored for up to 12 months

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

2 product images

  • Chemical Structure - Telmisartan, angiotensin II (AT1) antagonist (ab120831), expandable thumbnail

    Chemical Structure - Telmisartan, angiotensin II (AT1) antagonist (ab120831)

    2D chemical structure image of ab120831, Telmisartan, angiotensin II (AT1) antagonist

  • Functional Studies - Telmisartan, angiotensin II (AT1) antagonist (ab120831), expandable thumbnail

    Functional Studies - Telmisartan, angiotensin II (AT1) antagonist (ab120831)

    ab8934 staining PPARα in serum starved HepG2 cells treated with telmisartan (ab120831), by ICC/IF. Increase in PPARα expression correlates with increased concentration of telmisartan, as described in literature.
    The cells were incubated at 37°C for 6h in media containing different concentrations of ab120831 (telmisartan) in DMSO, fixed with 100% methanol for 5 minutes at -20°C and blocked with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% tween for 2h at room temperature. Staining of the treated cells with ab8934 (5 µg/ml) was performed overnight at 4°C in PBS containing 1% BSA and 0.1% tween. A DyLight 488 goat anti-rabbit polyclonal antibody (Goat Anti-Rabbit IgG H&L (DyLight® 488) preadsorbed ab96899) at 1/250 dilution was used as the secondary antibody. Nuclei were counterstained with DAPI and are shown in blue.

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com